Tweenvest Stocks

Exscientia plc (NasdaqGM: EXAI)

Health Care · Biotechnology · GB

$—

— today · — 1Y

Exscientia plc (NasdaqGM: EXAI) operates in the Biotechnology industry within the Health Care sector.

Tweenvest scores Exscientia plc across four factors: quality 47/100, value 43/100. Its strongest factor is quality.

EXAI price history

Not enough price history to draw a chart yet.

Key figures

Market cap
—
Revenue (TTM)
$22.88M
P/E
—
EPS
-1.19
Dividend yield
—
Beta (5Y)
—
52-week high
$—
52-week low
$—
Avg volume (3M)
—
Shares outstanding
—
Employees
483
Next earnings
—

About Exscientia plc

Exscientia plc is a pioneering pharmatech firm that leverages artificial intelligence (AI) to revolutionize drug discovery and development. The company provides a comprehensive, AI-driven platform that spans the entire drug development lifecycle. This integrated system supports crucial stages, including identifying disease targets, designing potential drug candidates, developing translational models, and optimizing patient selection for clinical trials. A key area of focus for Exscientia is the development of small molecule drug candidates. Through its advanced AI capabilities, the platform not only facilitates the efficient design of novel drug molecules but also employs AI-guided assessments to ensure patients receive the most suitable therapeutic interventions. Established in 2012, Exscientia plc is headquartered in Oxford, United Kingdom.

ISIN
US30223G1022
Founded
2012
Listed since
Oct 1, 2021
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
PhaseRx, Inc.OTCPK: PZRX.Q$12.00$——
ContraFect CorporationOTCPK: CFRX.Q$11.00$0.00—
Notable Labs, Ltd.OTCPK: NTBL.Q$10.00$——
OncoSec Medical IncorporatedOTCPK: ONCS.Q$6.00$0.00—
Calithera Biosciences, Inc.OTCPK: CALA$5.00$0.00-99.00%
Biocept, Inc.OTCPK: BIOC.Q$3.00$0.00-99.50%
Yield10 Bioscience, Inc.OTCPK: YTEN.Q$1.00$——
LadRx CorporationOTCPK: LADX$0.00$0.00-99.50%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.